Sign inGet started

Xmark Opportunity Partners, LLC

Insider CIK 1347039 · AOLS 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AOLS AEOLUS PHARMACEUTICALS, IN J Other deriv2013-02-192013-02-211,875,000— $00SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN J Other deriv2013-02-192013-02-211,875,000— $00SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN J Other deriv2013-02-192013-02-2143,614,285— $00SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN J Other deriv2013-02-192013-02-2111,785,714— $00SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN J Other deriv2013-02-192013-02-211,875,000— $01,875,000SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN J Other deriv2013-02-192013-02-211,875,000— $01,875,000SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN J Other deriv2013-02-192013-02-2143,614,285— $043,614,285SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN J Other deriv2013-02-192013-02-2111,785,714— $011,785,714SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN X Exercise deriv2013-02-192013-02-211,875,000— $00SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN X Exercise deriv2013-02-192013-02-211,875,000— $00SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN X Exercise deriv2013-02-192013-02-2143,614,285— $00SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN X Exercise deriv2013-02-192013-02-2111,785,714— $00SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN X Exercise2013-02-192013-02-2159,149,999— $098,725,838SEC↗
AOLS AEOLUS PHARMACEUTICALS, IN S Sale2013-02-192013-02-211,793,894$0.33 $592.0K96,931,944SEC↗